Volitionrx (VNRX) Cash from Operations Growth (5y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Volitionrx | 101.83 Mn | 99.36 Mn | -1.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -14.97% |
| Sep 30, 2025 | 4.20% |
| Jun 30, 2025 | -7.16% |
| Mar 31, 2025 | 2.18% |
| Dec 31, 2024 | -15.89% |
| Sep 30, 2024 | -7.70% |
| Jun 30, 2024 | -19.41% |
| Mar 31, 2024 | -17.97% |
| Dec 31, 2023 | 30.44% |
| Sep 30, 2023 | -12.78% |
| Jun 30, 2023 | -19.75% |
| Mar 31, 2023 | -20.05% |
| Dec 31, 2022 | -8.35% |
| Sep 30, 2022 | -19.29% |
| Jun 30, 2022 | -17.37% |
| Mar 31, 2022 | 27.37% |
| Dec 31, 2021 | -15.01% |
| Sep 30, 2021 | -18.19% |
| Jun 30, 2021 | -17.64% |
| Mar 31, 2021 | -23.32% |
| Dec 31, 2020 | -5.77% |
| Sep 30, 2020 | -13.95% |
| Jun 30, 2020 | -18.05% |
| Mar 31, 2020 | -16.82% |
| Dec 31, 2019 | -21.22% |
| Sep 30, 2019 | -33.90% |
| Jun 30, 2019 | -16.23% |
| Mar 31, 2019 | -30.15% |
| Dec 31, 2018 | -38.61% |
| Sep 30, 2018 | -41.00% |
| Jun 30, 2018 | -24.67% |
| Mar 31, 2018 | -44.51% |
| Dec 31, 2017 | -54.10% |
| Sep 30, 2017 | -31.30% |
| Jun 30, 2017 | -37.16% |
| Mar 31, 2017 | -36.47% |
| Dec 31, 2016 | -30.75% |
| Sep 30, 2016 | -36.57% |
| Jun 30, 2016 | -51.99% |
| Mar 31, 2016 | -44.91% |